查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2014390

低溫保存管瓶市場：依材料、容量、無菌性、封蓋方式、自動化能力、最終用戶和應用分類－2026-2032年全球市場預測

Cryogenic Vials Market by Material, Volume, Sterility, Closure, Automation Compatibility, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，低溫管瓶市場價值將達到 5.8267 億美元，到 2026 年將成長至 6.1815 億美元，到 2032 年將達到 8.9298 億美元，複合年成長率為 6.28%。

主要市場統計數據
基準年 2025 5.8267億美元
預計年份：2026年 6.1815億美元
預測年份 2032 8.9298億美元
複合年成長率 (%) 6.28%

本文簡明扼要地總結了為什麼在整個生命科學工作流程中選擇低溫管瓶會影響實驗室的可靠性、自動化相容性以及下游製程中樣品的價值。

低溫保存管瓶的發展趨勢支撐著生物醫學研究、診斷、生物銀行和治療藥物開發等關鍵工作流程。材料科學、封蓋技術以及與自動化系統的兼容性方面的最新創新，正將管瓶的作用從單純的容器提升為實驗室品質體係不可或缺的組成部分。隨著樣本完整性標準日益嚴格，處理能力需求不斷成長，實驗室和生物檢體資料庫正在重新評估供應商選擇標準，優先考慮無菌保證、可追溯性和與自動化平台的生命週期相容性。

材料、瓶蓋工程和與自動化相容性的進步正在重新定義產品標準、供應商驗證和採購期望。

低溫管瓶產業正經歷著由技術、監管和營運因素共同驅動的變革，這些因素共同重新定義了產品要求和供應商期望。聚合物化學和玻璃複合技術的進步提高了低溫耐受性並減少了洗脫，從而增強了檢體的長期儲存能力，並使其與高靈敏度檢測方法相容。同時，從改良的O型圈材料到磁性蓋和卡扣蓋設計，封蓋技術的創新正在解決洩漏風險，並確保日常操作中快速可靠地取用樣品。

了解美國關稅措施的變化將如何影響低溫管瓶相關人員的供應鏈策略、採購決策和業務永續營運。

美國關稅政策和貿易措施的變化將對低溫管瓶供應鏈中的組件採購、製造地地點和定價策略產生重大影響。進口前置作業時間及相關貿易限制的調整通常會導致海外產品和原料的交貨週期延長和接收成本增加。這些成本壓力往往迫使製造商重新評估其籌資策略，探索諸如近岸外包、回流生產或供應商多元化等方案，以降低風險並確保供應的連續性。

詳細的細分分析揭示了材料的化學性質、體積形式、封閉機制以及與自動化的兼容性如何影響產品設計和採購選擇。

細分市場趨勢揭示了整個低溫保存管瓶市場中產品設計和最終用戶需求的差異。材料選擇區分了玻璃和塑膠兩種途徑。玻璃製品，例如硼矽酸玻璃和鈉鈣玻璃，具有獨特的熱穩定性和化學穩定性，而塑膠製品，例如聚乙烯和聚丙烯，則具有更高的抗衝擊性，並且可以定製成型為適合自動化操作的形狀。因此，材料選擇需要在熱性能、與低溫儲存媒體的兼容性以及操作耐用性之間取得平衡，所有這些因素都會影響採購決策，而與實驗室類型無關。

美洲、歐洲、中東和非洲以及亞太地區的區域需求模式、管理體制和供應鏈基礎設施如何決定產品預期和市場進入策略。

區域趨勢塑造了美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、監管預期和供應商生態系統，從而對低溫保存管瓶相關人員產生獨特的營運和商業影響。在美洲，研究機構的集中、生物製藥開發以及成熟的生物銀行活動推動了對檢驗、文件齊全的產品和高服務水準的需求。在該地區，供應商的應對力、快速的前置作業時間以及適用於臨床研究和開發平臺的無菌認證產品線的供應至關重要。

競爭格局凸顯了檢驗的自動化準備、透明的品質系統和供應鏈韌性對於維持市場領先地位的重要性。

低溫保存管瓶產業的競爭動態取決於產品創新、生產規模以及檢驗是否符合實驗室自動化和監管要求的能力。領先的供應商透過投資先進材料、密封系統和滅菌檢驗來脫穎而出，而其他供應商則在成本和為大規模機構客戶提供客製化服務方面展開競爭。保存管瓶製造商與自動化供應商和實驗室整合商之間的策略夥伴關係，能夠降低整合風險並加速在高通量環境中的部署，從而提升價值提案。

為製造商和買家提供切實可行的策略行動，以加強檢驗能力、實現採購多元化並提高可追溯性，從而確保樣品完整性和供應連續性。

產業領導企業應採取切實可行的策略，使產品開發與不斷發展的實驗室工作流程、監管要求和供應鏈實際情況相契合。首先，他們應投資於跨職能驗證項目，以證明產品與領先的自動化平台相容，並為客戶提供清晰、可重複的驗收標準。此類驗證可降低整合風險，縮短引進週期，並在面向高通量實驗室和生物樣本庫的銷售中創造顯著的商業性優勢。

採用透明且多方面的研究途徑，結合與關鍵相關人員的訪談、技術文獻的整合以及產品驗證審查，為提出切實可行的建議奠定了基礎。

本研究採用結構化的調查方法，結合對關鍵相關人員的訪談、產品規格審查以及對監管指南和技術文獻的桌上研究，建構了穩健的分析基礎。關鍵資訊包括與檢查室經理、採購經理、品質保證負責人和產品工程師的對話，以了解營運挑戰、驗證要求和供應商選擇標準。這些定性見解與製造商的技術文件、滅菌規程和材料科學出版物進行交叉比對，以確保產品聲明與檢查室實際需求相符。

材料性能的整合、檢驗的自動化相容性以及強大的採購系統——這些對於保護檢體完整性和營運連續性至關重要。

總之，低溫保存管瓶領域正從簡單的通用容器轉變為對樣品完整性、檢查室處理能力和法規遵循至關重要的性能組件。材料創新和瓶蓋設計滿足了更嚴格的低溫保存和高靈敏度檢測的需求，而與自動化系統的兼容性正成為一項關鍵的商業性差異化因素，它能減少操作差異並加快實驗室工作流程。這些技術趨勢與地緣政治因素和關稅導致的供應鏈波動同步發展，因此需要製定積極主動的籌資策略和緊急時應對計畫。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：低溫保存管瓶市場：依材料分類

  • 玻璃
    • 硼矽酸玻璃
    • 鈉石灰
  • 塑膠
    • 聚乙烯
    • 聚丙烯

第9章：依容量分類的低溫保存管瓶市場

  • 1.5ml
  • 10ml
  • 2ml
  • 5ml

第10章：以滅菌狀態分類的低溫管瓶市場

  • 非無菌
  • 已滅菌

第11章：透過關閉低溫管瓶市場的方法

  • 磁性蓋
  • O型圈
  • 螺帽
  • 卡扣式帽

第12章：基於自動化方法的低溫管瓶市場

  • 全自動
  • 手動的
  • 半自動

第13章 低溫保存管瓶市場：依最終用戶分類

  • 學術和研究機構
  • 生物樣本庫
  • 生技公司
  • 診斷檢測實驗室
  • 醫院
  • 製藥公司

第14章 低溫保存管瓶市場：依應用領域分類

  • 冷凍保存
  • 檢體儲存
  • 運輸

第15章 低溫保存管瓶市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 低溫保存管瓶市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 低溫保存管瓶市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國低溫保存管瓶市場

第19章：中國低溫保存管瓶市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abdos Labtech Private Limited
  • Argos Technologies, Inc.
  • BioCision, LLC
  • Capp ApS
  • CELLTREAT Scientific Products
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Eppendorf AG
  • EZ BioResearch LLC
  • Greiner Bio-One International GmbH
  • Heathrow Scientific LLC
  • Micronic Holding BV
  • Sigma-Aldrich Corporation
  • Simport Scientific, Inc.
  • Starlab International GmbH
  • Sumitomo Bakelite Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC
Product Code: MRR-4311CE1A33F4

The Cryogenic Vials Market was valued at USD 582.67 million in 2025 and is projected to grow to USD 618.15 million in 2026, with a CAGR of 6.28%, reaching USD 892.98 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 582.67 million
Estimated Year [2026] USD 618.15 million
Forecast Year [2032] USD 892.98 million
CAGR (%) 6.28%

A concise framing of why cryogenic vial selection now drives laboratory integrity, automation compatibility, and downstream sample value across life sciences workflows

The cryogenic vial landscape underpins critical workflows across biomedical research, diagnostics, biobanking, and therapeutic development. Recent innovations in material science, closure technologies, and automation compatibility have elevated the role of vials from mere containers to integral components of laboratory quality systems. As sample integrity standards tighten and throughput demands increase, laboratories and biorepositories are recalibrating vendor selection criteria to prioritize sterility assurance, traceability, and lifecycle compatibility with automated platforms.

This introduction frames why cryogenic vial selection matters beyond simple storage. The interplay of material performance, closure reliability, and automation-readiness governs long-term sample viability and operational efficiency. Stakeholders from academic research labs to pharmaceutical development teams require vials that integrate seamlessly into workflows while meeting regulatory expectations for sterility and contamination control. Consequently, procurement decisions now hinge on a multidimensional assessment of product attributes, supplier capabilities, and downstream operational impacts rather than price alone.

Looking forward, market participants should expect procurement and R&D teams to demand standardized specifications that reduce variability across supply chains and support interoperability with automated systems. This introduction sets the stage for a deeper exploration of transformative industry shifts, tariff-driven supply chain pressures, segmentation nuances, regional differences, competitive dynamics, and practical recommendations for leaders seeking to navigate a rapidly evolving ecosystem.

How advances in materials, closure engineering, and automation compatibility are converging to redefine product standards, supplier validation, and procurement expectations

The cryogenic vial sector is experiencing transformative shifts driven by technological, regulatory, and operational vectors that collectively redefine product requirements and supplier expectations. Advances in polymer chemistry and glass formulations are delivering improved low-temperature resilience and reduced leachables, enabling longer-term sample preservation and greater compatibility with high-sensitivity assays. At the same time, closure innovations-ranging from enhanced O-ring materials to magnetic and snap cap designs-are addressing leakage risk and facilitating rapid, reliable access during routine handling.

Concurrently, the automation wave is reshaping procurement priorities: fully automated and semi-automated systems demand standardized vial geometries, robust closure interfaces, and consistent manufacturing tolerances to ensure pick-and-place reliability. This shift places a premium on vendors that can validate compatibility and provide test data for robotic handling. Regulatory and quality expectations are also tightening; suppliers are being asked to present sterilization validation, traceability records, and material safety documentation as part of standard commercial engagement.

Finally, supply chain resilience and environmental considerations are pushing manufacturers to optimize logistics and explore recyclable or lower-carbon material choices. These converging forces are compelling incumbents and new entrants alike to invest in product differentiation, certification pathways, and collaborative validation with end users to remain competitive in an increasingly exacting market.

Understanding how shifts in United States tariff measures influence supply chain strategy, sourcing decisions, and operational continuity for cryogenic vial stakeholders

Tariff policy developments and trade measures emanating from the United States can exert outsized influence on component sourcing, manufacturing footprints, and pricing strategies within the cryogenic vial supply chain. When import duties or related trade restrictions are adjusted, downstream purchasers frequently encounter longer procurement lead times and higher landed costs for products or raw inputs sourced internationally. These cost pressures often encourage manufacturers to reassess sourcing strategies, which can include nearshoring, reshoring, or diversifying supplier bases to mitigate risk and stabilize supply continuity.

The cumulative effect of tariff changes in a given policy cycle typically reverberates through manufacturing decisions and inventory strategies. Suppliers may accelerate vertical integration to internalize critical processes and reduce exposure to duty fluctuations, or they may renegotiate contractual terms related to cost-pass-through to end buyers. Operationally, laboratory and biobank managers may face intermittent SKU rationalization as vendors prioritize core SKUs that are more economically viable under new trade conditions. In parallel, organizations that rely on specialized glass formulations or specific polymer grades could face procurement friction if those feedstocks are concentrated in jurisdictions affected by tariffs.

To navigate these dynamics, commercial leaders should incorporate tariff scenario planning into sourcing and pricing frameworks, evaluate alternate material or supplier options early, and engage in collaborative forecasting with trusted suppliers. Transparent dialogue about cost composition and contingency plans will help stabilize supply chains, preserve product quality, and maintain service levels even when trade policy shifts create transient market dislocations.

Deep segmentation analysis revealing how material chemistry, volume formats, closure mechanisms, and automation compatibility sculpt product design and procurement choices

Segment-level dynamics illuminate how product design and end-user requirements diverge across the cryogenic vial landscape. Material selection distinguishes glass and plastic pathways, where glass variants such as borosilicate and soda lime offer differing thermal and chemical stability profiles, and plastic options including polyethylene and polypropylene provide enhanced impact resistance and customizable molding for automation-friendly geometries. Decisions about material thus balance thermal performance, compatibility with cryopreservation media, and handling durability, influencing procurement choices across laboratory types.

Volume segmentation, spanning formats like 1.5ml, 2ml, 5ml, and 10ml, maps directly to sample type and throughput considerations; smaller volumes support microtiter workflows and high-density biobanking while larger formats address bulk storage and transport use cases. Sterility classification into non-sterile and sterile offerings shapes market expectations for sterilization validation and packaging controls, particularly where clinical or regulated research samples are involved. Closure systems-magnetic closure, O-ring, screw cap, and snap cap-represent a critical interface with containment integrity and rapid access, with each closure type offering trade-offs between leak resistance, automation compatibility, and user ergonomics.

Automation compatibility divides products into fully automated, semi-automated, and manual categories and drives design tolerances, insertion/retrieval reliability, and barcode or rack-interface requirements. End-user segmentation covering academic and research institutes, biobanks, biotechnology firms, diagnostic laboratories, hospitals, and pharmaceutical companies underscores how performance expectations vary by application context, regulatory burden, and throughput needs. Finally, application-focused distinctions such as cryopreservation, sample storage, and transport concentrate functional demands; for example, transport vials prioritize shock resistance and secure closures, whereas cryopreservation vials emphasize thermal cycling durability and minimal extractables. Together, these segmentation layers form a matrix that informs product roadmaps, validation commitments, and commercial positioning for suppliers seeking to align with customer requirements.

How regional demand patterns, regulatory regimes, and supply chain infrastructures across the Americas, EMEA, and Asia-Pacific determine product expectations and go-to-market strategies

Regional dynamics shape demand drivers, regulatory expectations, and supplier ecosystems across the Americas, Europe, Middle East & Africa, and Asia-Pacific, producing distinctive operational and commercial implications for cryogenic vial stakeholders. In the Americas, a concentration of research institutions, biopharmaceutical development, and established biobanking activity fuels demand for validated, heavily documented products and high service-level expectations. This region places a premium on supplier responsiveness, rapid lead times, and the availability of sterile, certified product lines suitable for clinical R&D pipelines.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and a dense network of clinical laboratories guide product compliance and traceability practices. Suppliers active in this region must navigate a mosaic of national regulations while meeting stringent quality system requirements, often supporting multilingual documentation and regional distribution strategies. In the Asia-Pacific region, rising research investment, expanding biotech clusters, and growing diagnostic capacity drive broad-based demand for both cost-effective plastic solutions and high-performance glass offerings. Manufacturers targeting this region frequently emphasize scalable production, local partnerships, and customization to support diverse end-user profiles.

Collectively, these regional patterns suggest that suppliers will benefit from tailored go-to-market approaches that combine global product standards with localized support, regulatory expertise, and logistics solutions that address regional infrastructure and procurement behaviors.

Competitive landscape pressures highlight the importance of validated automation compatibility, transparent quality systems, and supply chain resilience for market leadership

Competitive dynamics within the cryogenic vial sector are defined by product innovation, manufacturing scale, and the ability to validate compatibility with laboratory automation and regulatory requirements. Leading suppliers differentiate through investments in advanced materials, closure systems, and sterilization validation, while others compete on cost and customization capacity for large institutional clients. Strategic partnerships between vial manufacturers and automation vendors or laboratory integrators enhance the value proposition by reducing integration risk and accelerating adoption in high-throughput environments.

Supply-side competitiveness also rests on quality management systems and the transparency of material and process documentation. Firms that offer robust traceability, lot-level testing, and third-party certifications typically secure preferred supplier status among clinical and pharmaceutical end users. Manufacturing footprint and supply chain resilience constitute another axis of competitiveness; companies with diversified production locations or strong regional distribution networks are better positioned to absorb tariff shocks and logistics disruptions.

Finally, emerging entrants focusing on sustainability credentials, recyclable materials, or novel closure technologies are reshaping buyer expectations. Incumbent vendors may respond through incremental product enhancements or strategic M&A to expand portfolios and accelerate time-to-market for validated, automation-ready offerings. Overall, competitive success increasingly requires not just a strong product, but demonstrable quality systems, validation support, and operational reliability aligned with customer workflows.

Practical strategic actions for manufacturers and purchasers to strengthen validation capability, diversify inputs, and enhance traceability to safeguard sample integrity and supply continuity

Industry leaders should pursue actionable strategies that align product development with evolving laboratory workflows, regulatory expectations, and supply chain realities. First, invest in cross-functional validation programs that demonstrate reliable performance with leading automation platforms and provide customers with clear, reproducible acceptance criteria. Such validation reduces integration risk, shortens adoption cycles, and creates a defensible commercial advantage when selling into high-throughput laboratories and biobanks.

Second, strengthen material and closure diversification to mitigate exposure to input-specific supply disruptions. By qualifying alternate glass formulations and polymer grades, and by validating multiple closure types for key SKUs, manufacturers can respond more nimbly to tariff shifts, raw material scarcity, or sudden demand spikes. Third, enhance documentation and traceability offerings by providing sterilization certificates, extractables/leachables data, and lot-level traceability to meet the documentation needs of clinical and pharmaceutical customers. Clear documentation supports procurement evaluation and reduces time-to-qualification for regulated buyers.

Fourth, prioritize regional manufacturing and distribution partnerships to shorten lead times and lower freight sensitivity, while exploring sustainable material choices and packaging optimizations to respond to customer ESG goals. Finally, engage proactively with end users through collaborative pilots, custom validation projects, and educational programming to ensure product designs address real-world handling challenges and preserve sample integrity throughout the sample lifecycle.

A transparent and triangulated research approach combining primary stakeholder interviews, technical literature synthesis, and product validation reviews to ground practical recommendations

This research relied on a structured methodology combining primary stakeholder interviews, product specification reviews, and desk-based synthesis of regulatory guidance and technical literature to construct a robust analytical foundation. Primary inputs included dialogues with laboratory managers, procurement leads, quality assurance professionals, and product engineers to capture operational pain points, validation requirements, and vendor selection criteria. These qualitative insights were triangulated with technical documentation from manufacturers, sterilization protocols, and materials science publications to ensure alignment between claimed product performance and practical laboratory needs.

Secondary analysis incorporated public regulatory guidance, standards documents, and peer-reviewed research on cryopreservation, material stability at ultra-low temperatures, and closure performance. Where appropriate, comparative evaluation of design attributes was performed to assess automation compatibility, closure integrity, and material-related risks such as extractables. The methodological approach emphasized transparency in source attribution, careful treatment of proprietary claims, and scenario-based analysis for supply chain and policy impacts to guide practical recommendations.

Limitations of the methodology include variability in vendor documentation practices and the evolving nature of automation standards, which can affect generalizability. To mitigate these limitations, the approach prioritized cross-validation across multiple independent sources and incorporated end-user testing feedback where available to ground findings in operational reality.

Synthesis of why material performance, validated automation compatibility, and resilient sourcing are essential to protect sample integrity and operational continuity

In conclusion, the cryogenic vial landscape is transitioning from commoditized containers to performance-critical components that influence sample integrity, laboratory throughput, and regulatory compliance. Material innovations and closure engineering are meeting the demands of more rigorous cryopreservation and high-sensitivity assays, while automation compatibility is emerging as a key commercial differentiator that reduces handling variability and accelerates laboratory workflows. These technological trends are occurring alongside geopolitical and tariff-driven supply chain dynamics that require proactive sourcing strategies and contingency planning.

For stakeholders across research institutions, diagnostics, biobanking, and pharmaceutical organizations, the path forward includes prioritizing validated compatibility with automation, insisting on comprehensive documentation and traceability, and engaging suppliers that demonstrate operational resilience and regional support capabilities. Manufacturers that invest in material diversification, validated closures, and collaborative validation programs will be better positioned to meet the tightening quality and throughput expectations of modern laboratories.

Taken together, these developments underscore the need for a strategic, evidence-based approach to vial selection and supply chain design that preserves sample value, minimizes operational risk, and aligns product capabilities with evolving laboratory workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cryogenic Vials Market, by Material

  • 8.1. Glass
    • 8.1.1. Borosilicate
    • 8.1.2. Soda Lime
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polypropylene

9. Cryogenic Vials Market, by Volume

  • 9.1. 1.5ml
  • 9.2. 10ml
  • 9.3. 2ml
  • 9.4. 5ml

10. Cryogenic Vials Market, by Sterility

  • 10.1. Non Sterile
  • 10.2. Sterile

11. Cryogenic Vials Market, by Closure

  • 11.1. Magnetic Closure
  • 11.2. O Ring
  • 11.3. Screw Cap
  • 11.4. Snap Cap

12. Cryogenic Vials Market, by Automation Compatibility

  • 12.1. Fully Automated
  • 12.2. Manual
  • 12.3. Semi Automated

13. Cryogenic Vials Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Biobanks
  • 13.3. Biotechnology Firms
  • 13.4. Diagnostic Laboratories
  • 13.5. Hospitals
  • 13.6. Pharmaceutical Companies

14. Cryogenic Vials Market, by Application

  • 14.1. Cryopreservation
  • 14.2. Sample Storage
  • 14.3. Transport

15. Cryogenic Vials Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Cryogenic Vials Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Cryogenic Vials Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Cryogenic Vials Market

19. China Cryogenic Vials Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abdos Labtech Private Limited
  • 20.6. Argos Technologies, Inc.
  • 20.7. BioCision, LLC
  • 20.8. Capp ApS
  • 20.9. CELLTREAT Scientific Products
  • 20.10. Corning Incorporated
  • 20.11. DWK Life Sciences GmbH
  • 20.12. Eppendorf AG
  • 20.13. EZ BioResearch LLC
  • 20.14. Greiner Bio-One International GmbH
  • 20.15. Heathrow Scientific LLC
  • 20.16. Micronic Holding B.V.
  • 20.17. Sigma-Aldrich Corporation
  • 20.18. Simport Scientific, Inc.
  • 20.19. Starlab International GmbH
  • 20.20. Sumitomo Bakelite Co., Ltd.
  • 20.21. Thermo Fisher Scientific, Inc.
  • 20.22. VWR International, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. GCC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 191. GCC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 192. GCC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 193. GCC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. G7 CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 220. G7 CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 221. G7 CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 222. G7 CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 223. G7 CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. NATO CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 231. NATO CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 232. NATO CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. NATO CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)